scholarly article | Q13442814 |
P356 | DOI | 10.1016/0002-9149(84)90696-9 |
P698 | PubMed publication ID | 6419573 |
P2093 | author name string | Franciosa JA | |
Schwartz DE | |||
Leddy CL | |||
Wilen M | |||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | congestive heart failure | Q19000661 |
heart failure | Q181754 | ||
hemodynamics | Q1642137 | ||
P304 | page(s) | 127-134 | |
P577 | publication date | 1984-01-01 | |
P1433 | published in | American Journal of Cardiology | Q2208417 |
P1476 | title | Relation between hemodynamic and ventilatory responses in determining exercise capacity in severe congestive heart failure. | |
P478 | volume | 53 |
Q71810374 | Acute Alterations of Oxygen Uptake and Symptom-Limited Exercise Time in Patients With Mitral Stenosis After Balloon Valvuloplasty |
Q84186860 | Alterations in the large peripheral circulation in dogs with heart failure |
Q37738038 | Cardiac rehabilitation in heart failure: a brief review and recommendations |
Q34191743 | Causes of Breathing Inefficiency During Exercise in Heart Failure |
Q77989584 | Central and peripheral components of chronic heart failure: determinants of exercise tolerance |
Q36814370 | Central haemodynamics and peripheral muscle function during exercise in patients with chronic heart failure |
Q73407528 | Clinical correlates and prognostic significance of the ventilatory response to exercise in chronic heart failure |
Q78805279 | Clinical predictors of exercise capacity 1 year after cardiac transplantation |
Q73353355 | Dependence of peak oxygen uptake on oxygen transport capacity in chronic heart failure: comparison of graded protocol and fixed protocol |
Q33591972 | Determinants of ventilatory efficiency in heart failure: the role of right ventricular performance and pulmonary vascular tone |
Q35369810 | Echo derived variables predicting exercise tolerance in patients with dilated and poorly functioning left ventricle |
Q73189779 | Effect of angiotensin-converting enzyme inhibitor (enalapril or imidapril) on ventilation during exercise in patients with chronic heart failure secondary to idiopathic dilated cardiomyopathy |
Q70076966 | Effects of enalapril, a new angiotensin-converting enzyme inhibitor, in a controlled trial in heart failure |
Q73095301 | Effects of isosorbide dinitrate on electrocardiography, hemodynamics, and ventilation in patients with exercise-induced elevation of pulmonary artery wedge pressure |
Q74012881 | End-tidal CO2 pressure decreases during exercise in cardiac patients: association with severity of heart failure and cardiac output reserve |
Q50664343 | Evaluation of exercise capacity using wave intensity in chronic heart failure with normal ejection fraction. |
Q46834633 | Exercise hyperventilation in chronic heart failure is not caused by systemic lactic acidosis |
Q40457694 | Exercise intolerance in patients with chronic heart failure. |
Q41187847 | Exercise limitation in chronic heart failure: central role of the periphery |
Q36287326 | Exercise training as therapy for chronic heart failure |
Q71735898 | Exertional hyperpnea in patients with chronic heart failure is a reversible cause of exercise intolerance |
Q33999109 | Factors determining symptoms in heart failure: comparison of fast and slow exercise tests |
Q77353810 | Factors influencing exercise performance in patients with left ventricular dysfunction. SOLVD Investigators. Studies of Left Ventricular Dysfunction |
Q71663025 | Factors which alter the relationship between ventilation and carbon dioxide production during exercise in normal subjects |
Q33999345 | Failure of propranolol to improve exercise tolerance in patients with mitral stenosis in sinus rhythm |
Q38112052 | Gas exchange consequences of left heart failure |
Q88773877 | Haemodynamics, dyspnoea, and pulmonary reserve in heart failure with preserved ejection fraction |
Q88871551 | Hemodynamic Correlates and Diagnostic Role of Cardiopulmonary Exercise Testing in Heart Failure With Preserved Ejection Fraction |
Q54117280 | Impaired ventilatory efficiency in chronic heart failure: possible role of pulmonary vasoconstriction. |
Q40140048 | Increased Dead Space Ventilation Mediates Reduced Exercise Capacity in Systolic Heart Failure. |
Q33613981 | Increased alveolar/capillary membrane resistance to gas transfer in patients with chronic heart failure |
Q97883096 | Measurement and Interpretation of Exercise Ventilatory Efficiency |
Q33610840 | Mechanism of the increased ventilatory response to exercise in patients with chronic heart failure |
Q35572255 | Modulation of ventilatory reflex control by cardiac resynchronization therapy |
Q69893199 | Non-invasive measurement of cardiac output |
Q71807871 | Peak Oxygen Consumption and Resting Left Ventricular Ejection Fraction Changes After Cardiomyoplasty at 6-Month Follow-up |
Q47822324 | Peak oxygen uptake. Myth and truth about an internationally accepted reference value. |
Q36821415 | Perfusion/ventilation mismatch during exercise in chronic heart failure: an investigation of circulatory determinants |
Q34469508 | Physiological cardiac reserve: development of a non-invasive method and first estimates in man. |
Q73662433 | Plasma clearance of polyfructosan and extracellular body fluid distribution in idiopathic dilated cardiomyopathy and after heart transplantation |
Q36364556 | Prognostic role of cardiac power index in ambulatory patients with advanced heart failure |
Q40542582 | Pulmonary factors limiting exercise capacity in patients with heart failure |
Q73690986 | Relationship between exercise hyperpnea, hemodynamics, and blood gases before and during glyceryl trinitrate infusion in patients with exercise-induced elevation of pulmonary artery wedge pressure |
Q36760225 | Respiratory gas exchange in the assessment of patients with impaired ventricular function |
Q67921197 | Respiratory muscle deoxygenation during exercise in patients with heart failure demonstrated with near-infrared spectroscopy |
Q46153126 | Resting muscle sympathetic nerve activity, cardiac metaiodobenzylguanidine uptake, and exercise tolerance in patients with left ventricular dysfunction |
Q73614661 | Short-term reproducibility of cardiopulmonary measurements during exercise testing in patients with severe chronic heart failure |
Q35162695 | Skeletal muscle abnormalities in chronic heart failure patients: relation to exercise capacity and therapeutic implications |
Q46907697 | Spectral analysis of femoral artery blood flow waveforms of conscious domestic cats. |
Q34285408 | Symptoms limiting exercise in chronic heart failure |
Q73164958 | The effect of specific inspiratory muscle training on the sensation of dyspnea and exercise tolerance in patients with congestive heart failure |
Q36840418 | The increased ventilatory response to exercise in chronic heart failure: relation to pulmonary pathology |
Q39492159 | The management of heart failure: a matter of definition? |
Q51647944 | The measurement of extravascular lung density with SPECT imaging and its relationship with ventilatory abnormalities in patients with congestive heart failure |
Q34247669 | The physiology behind exercise testing |
Q39511387 | The role of exercise testing in chronic heart failure |
Q33823518 | The role of exercise testing in the evaluation and management of heart failure |
Q34487586 | Treatment of chronic heart failure: a review of recent drug trials |
Q33613840 | Usefulness of arterial blood gas estimations during exercise in patients with chronic heart failure |
Q42087276 | Ventilation in chronic heart failure: effects of physical training |
Q36980906 | Ventricular-vascular interaction in heart failure |
Q41564600 | What can we learn from exercise testing beyond the detection of myocardial ischemia? |